Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

Retrovirus-mediated IL-4 gene therapy in spontaneous adenocarcinomas from MMTV-neu transgenic mice

Abstract

Gene therapy approaches to the treatment of experimental cancer are usually based on established neoplastic cell lines which are manipulated in vitro and subsequently transplanted in host animals. However, the relevance of these artificial models to the biology and therapy of human tumors is uncertain. We have previously validated an experimental model based on MMTV-neu transgenic mice in which breast tumors arise spontaneously in 100% of animals and have many features in common with their human counterpart, including the involvement of the neu oncogene and the ability to metastatize. In this article we report the effect of intratumoral, retrovirus-mediated, IL-4 expression on the growth of breast tumors arising in these mice. The size of IL-4 inoculated tumors on the right side was significantly smaller than that of controlateral untreated tumors, suggesting a local effect of IL-4. In addition, the non-injected tumors on the left side of treated animals were significantly smaller than those arising in control transgenic mice, suggesting that IL-4 can also inhibit tumor growth systemically. These findings suggest that IL-4 gene transfer can significantly reduce the growth rate of spontaneously arising breast tumors and that immune-based gene therapy could efficiently complement other approaches based on different mechanisms, such as suicide gene transfer or antisense technology.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Hanahan D . Transgenic mice as probes into complex systems Science 1989 246: 1265–1275

    Article  CAS  Google Scholar 

  2. Pattengale PK et al. Animal models of human disease. Pathology and molecular biology of spontaneous neoplasms occurring in transgenic mice carrying and expressing activated cellular oncogenes Am J Pathol 1989 135: 39–61

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Jacks T . Tumor suppressor gene mutations in mice Annu Rev Genet 1996 30: 603–636

    Article  CAS  Google Scholar 

  4. Sacco MG et al. Partial regression, yet incomplete eradication of mammary tumors in transgenic mice by retrovirus-mediated HSVtk transfer in vivo Gene Therapy 1996 3: 1151–1156

    CAS  PubMed  Google Scholar 

  5. Sacco MG et al. In vitro and in vivo antisense-mediated growth inhibition of a mammary adenocarcinoma from MMTV-neu transgenic mice Gene Therapy 1998 5: 388–393

    Article  CAS  Google Scholar 

  6. Sacco MG et al. Local regression of breast tumors following intrammary ganciclovir administration in double transgenic mice expressing neu oncogene and herpes simplex virus thymidine kinase Gene Therapy 1995 2: 493–497

    CAS  PubMed  Google Scholar 

  7. Sacco MG et al. Establishment and characterization of a new mammary adenocarcinoma cell line derived from MMTV neu transgenic mice Breast Cancer Res Treat 1998 47: 171–180

    Article  CAS  Google Scholar 

  8. Lucchin F et al. Early and multifocal tumors in breast, salivary, harderian and epididimal tissues developed in MMTV-Neu transgenic mice Cancer Lett 1992 64: 203–209

    Article  Google Scholar 

  9. Boggio K et al. Interleukin-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/Neu transgenic mice J Exp Med 1998 188: 589–596

    Article  CAS  Google Scholar 

  10. Rogulski KR, Kim JH, Kim SH, Freytag SO . Glioma cells transduced with an E. coli CD/HSV-1 TK fusion gene exhibit enhanced metabolic suicide and radiosensitivity Hum Gene Ther 1997 8: 73–85

    Article  CAS  Google Scholar 

  11. Heise C et al. ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolisis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents Nature Med 1997 3: 639–645

    Article  CAS  Google Scholar 

  12. Freytag SO et al. A novel three-pronged approach to kill cancer cells selectively: concomitant viral, double suicide gene and radiotherapy Hum Gene Ther 1998 9: 1323–1333

    Article  CAS  Google Scholar 

  13. Tepper RI, Pattengale PK, Leder P . Murine interleukin-4 displays potent anti-tumor activity in vivo Cell 1989 57: 503–512

    Article  CAS  Google Scholar 

  14. Hoon DSB et al. Modulation of human melanoma cells by interleukin 4 and in combination with γ-interferon or α-tumor necrosis factor Cancer Res 1991 51: 2002–2008

    CAS  PubMed  Google Scholar 

  15. Morisaki T et al. Interleukin 4 regulates G1 cell cycle progression in gastric carcinoma cells Cancer Res 1994 54: 1113–1118

    CAS  PubMed  Google Scholar 

  16. Topp MS et al. Recombinant human interleukin 4 has antiproliferative activity on human tumor cell lines derived from epithelial and nonepithelial histologies Cancer Res 1995 55: 2173–2176

    CAS  PubMed  Google Scholar 

  17. Toi M, Bicknell R, Harris AL . Inibition of colon and breast carcinoma cell growth by interleukin 4 Cancer Res 1992 52: 275–279

    CAS  PubMed  Google Scholar 

  18. Blais Y et al. Interleukin 4 and interleukin 13 inhibit estrogen-induced breast cancer cell proliferation and stimulate GCDFP-15 expression in human breast cancer cells Mol Cell Endocrinol 1996 121: 11–18

    Article  CAS  Google Scholar 

  19. Gooch JL, Lee AV, Yee D . Interleukin 4 inhibits growth and induces apoptosis in human breast cancer cells Cancer Res 1998 58: 4199–4205

    CAS  PubMed  Google Scholar 

  20. Paillard F . Cancer cells under the fire of combined therapies Hum Gene Ther 1998 9: 1259–1260

    Article  CAS  Google Scholar 

  21. Paul WE . Interleukin-4: a prototypic immunoregulatory lymphokine Blood 1991 77: 1859–1870

    CAS  PubMed  Google Scholar 

  22. Colombo MP, Modesti A, Parmiani G, Forni G . Local cytokine availability elicits tumor rejection and systemic immunity through granulocyte-T lymphocyte cross-talk Cancer Res 1992 52: 4853–4857

    CAS  PubMed  Google Scholar 

  23. Pericle F et al. An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4 J Immunol 1994 153: 5659–5673

    CAS  PubMed  Google Scholar 

  24. Volpert O et al. Inhibition of angiogenesis by interleukin 4 J Exp Med 1998 188: 1039–1046

    Article  CAS  Google Scholar 

  25. Colombo BM et al. The ‘bystander effect’: association of U-87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice Hum Gene Ther 1995 6: 763–772

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The technical assistance of Dario Strina, Angela Pettinicchio and Remo Di Bacco is acknowledged. We thank Prof R Dulbecco for encouragement and Ms Victoria Starnes for typing the manuscript. The financial support of AIRC to AV is gratefully acknowledged. This is manuscript No. 28 of the Genoma 2000/ITBA Project funded by CARIPLO. SB is supported by a fellowship from AIRC.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sacco, M., Benedetti, S., Catò, E. et al. Retrovirus-mediated IL-4 gene therapy in spontaneous adenocarcinomas from MMTV-neu transgenic mice. Gene Ther 6, 1893–1897 (1999). https://doi.org/10.1038/sj.gt.3301017

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3301017

Keywords

This article is cited by

Search

Quick links